BPG is committed to discovery and dissemination of knowledge
Retrospective Study
Copyright: ©Author(s) 2026.
World J Clin Oncol. May 24, 2026; 17(5): 117168
Published online May 24, 2026. doi: 10.5306/wjco.v17.i5.117168
Figure 1
Figure 1 Survival curves of the adolescent and young adult (AYA) and non-AYA groups. A: Overall survival curve for patients in the adolescent and young adult (AYA) and non-AYA groups; B: Recurrence-free survival curve for patients in the AYA and non-AYA groups. AYA: Adolescent and young adult; HCC: Hepatocellular carcinoma.
Figure 2
Figure 2 Abdominal computed tomography images demonstrating a 10-cm tumor in segment 6 of the liver. A slightly strong uptake of the contrast agent was observed in the hepatic arterial phase, and the lesion became isodense during the portal venous, hepatic venous, and equilibrium phases (arrows).
Figure 3
Figure 3 Pathological findings of the resected tumor. A: Gross specimen showing a 100-mm × 80-mm lesion with expansive growth; B: Histological examination revealing moderately differentiated hepatocellular carcinoma without vascular invasion (pT1bN0M0, pathological stage IB; Union for International Cancer Control, 8th edition).
Figure 4
Figure 4 Positron emission tomography findings demonstrating pulmonary metastasis (arrow). A: Plane computed tomography (CT) image; B: Positron emission tomography (PET)-CT axial image; C: Coronal PET-CT image.
Figure 5
Figure 5 Pathological findings of the pulmonary lesion. A: Resected lung specimen; B: Histopathological examination confirming pulmonary metastasis from hepatocellular carcinoma.


Write to the Help Desk